Abiomed receives conditional approval for AMI trial
This approval is conditional upon the company’s submission of additional information to the FDA over the next 45 days. The AMI shock study will determine the safety and

This approval is conditional upon the company’s submission of additional information to the FDA over the next 45 days. The AMI shock study will determine the safety and

These stents are indicated for use in the palliative treatment of malignant strictures in the biliary tree that can restrict the flow of digestive fluids and compromise digestion.

The warrants have a seven year term and an exercise price of $2.77 per share. The transaction is expected to raise approximately $25.3 million in gross proceeds. The

Avance Nerve Graft is said to be the only off-the-shelf product available that gives surgeons the option to repair damaged peripheral nerves with human allograft nerve. Avance Nerve

The financing was led by Saad Investments Company and included Masa Life Science Ventures of Washington, District of Columbia and private investors. Eric Adams, president and CEO of

The Phase IIb trial is a US multi-center, randomized, parallel, open-label study in 278 treatment-naive, genotype 1 patients evaluating taribavirin at 20mg/kg, 25mg/kg, and 30mg/kg per day in

The study examined the safety of Symbicort in children for 26 weeks and also included efficacy measures. For children previously treated with inhaled corticosteroid, either alone or in

Alimera is increasing its equity in the future profits of Medidur FA from 50 to 80% in exchange for consideration of up to approximately $78 million to pSivida.

A clinical hold is an order issued by FDA to the sponsor to delay a proposed clinical trial or suspend an ongoing clinical trial. The FDA has placed

In the open-label, single-arm Phase II trial (Sonoma-3), alfimeprase restored catheter function in approximately 50% of patients at 15 minutes and approximately 60% of patients at one hour.